LLY Competitors & Alternatives
Compare Eli Lilly and Company with similar stocks in the same industry
Drug Manufacturers - General
LLY
Main Stock$1443.50
Tradestie Score
39
Market Cap
$739.95B
P/E Ratio
46.3
Revenue Growth
0.4%
Analyst Upside
+1.2%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 5/10
Drug Discovery Biotech
Drug Design
Major Customers
5
Retail pharmacies
Wholesalers (McKesson, Cardinal Health)
Hospitals and clinics
Specialty pharmacies
Government programs (Medicare/Medicaid)
Critical Suppliers
5
Contract manufacturing organizations (CMOs)
API chemical suppliers
Clinical research organizations (CROs)
Biotech research partners
Raw material providers
Top Competitors
18 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AVGO
Broadcom Inc. Common Stock
|
$347.01
|
$1.57T | 46.5 | 52 | Compare |
|
JNJ
Johnson & Johnson
|
$285.75
|
$448.07B | 43.0 | 53 | Compare |
|
ABBV
ABBVIE INC.
|
$295.03
|
$431.71B | 50.6 | 49 | Compare |
|
NVO
Novo-Nordisk A/S
|
$41.63
|
$262.92B | 10.4 | 45 | Compare |
|
AZN
AstraZeneca PLC
|
$184.45
|
$261.56B | 26.1 | 37 | Compare |
|
NVS
Novartis AG
|
$160.50
|
$254.99B | 30.6 | 36 | Compare |
|
ABT
Abbott Laboratories
|
$108.52
|
$232.30B | 40.0 | 49 | Compare |
|
MRK
Merck & Co., Inc.
|
$147.76
|
$225.13B | 148.4 | 53 | Compare |
|
AMGN
Amgen Inc
|
$465.67
|
$160.70B | 27.1 | 39 | Compare |
|
PFE
Pfizer Inc.
|
$28.89
|
$154.70B | 41.2 | 49 | Compare |
More LLY Analysis
Data updated: Nov 15, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
18 stocks in this industry